Enliven Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
AVTE
Aerovate Therapeutics, Inc. |
$2.69 | $77.97 M | -1.1 | 30 |
CELC
Celcuity Inc. |
$9.99 | $378.02 M | -3.53 | 87 |
CGEM
Cullinan Oncology, Inc. |
$7.61 | $445.28 M | -2.74 | 111 |
CMPX
Compass Therapeutics, Inc. |
$1.71 | $236.46 M | -4.75 | 35 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $342.68 M | -2.3 | 9 |
GOSS
Gossamer Bio, Inc. |
$0.83 | $188.59 M | -3.32 | 144 |
GPCR
Structure Therapeutics Inc. |
$18.51 | $353.46 M | -7.91 | 163 |
IMRX
Immuneering Corporation |
$1.25 | $44.86 M | -0.61 | 66 |
INBX
Inhibrx Biosciences, Inc. |
$11.52 | $166.76 M | 0.1 | 156 |
KRON
Kronos Bio, Inc. |
$0.88 | $53.65 M | -0.62 | 10 |
LYRA
Lyra Therapeutics, Inc. |
$0.09 | $5.93 M | -0.06 | 30 |
MACK
Merrimack Pharmaceuticals, Inc. |
$15.15 | $223.97 M | -168.28 | 0 |
MLTX
MoonLake Immunotherapeutics |
$37.00 | $2.34 B | -19.58 | 100 |
NVCT
Nuvectis Pharma, Inc. |
$8.88 | $207.72 M | -8 | 13 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.00 | $51.93 M | -0.88 | 47 |
REPL
Replimune Group, Inc. |
$7.64 | $588.39 M | -2.49 | 331 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
